SEARCH RESULTS FOR:
Trade Agreements: USMCA replaces good old NAFTA
Latin America Petrochemicals and Chemicals 2018 APLA Special Edition
Bilateral trade between USA and Mexico will not be greatly damaged by the new regulations, but Mexico is nevertheless signing new trade agreements elsewhere to diversify its trade.
The Indispensable Partner: Contract Services
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.
Pramod Thota
PRESIDENT, FMC INDIA
India Chemicals 2018 Pre-Release Edition
Following its recent acquisition of Dupont’s agro business, FMC is well positioned to extend its dominance of India’s crop protection industry.
Latin American Petrochemicals: Decision Making Time
Latin America Petrochemicals and Chemicals 2018 APLA Special Edition
The region has resources and a growing demand, but faces political and infrastructure challenges.
Bob Patel
CEO, LYONDELLBASELL
Latin America Petrochemicals and Chemicals 2018 APLA Special Edition
LyondellBasell explains why the company is eager to expand on a grand scale into Latin America.
Fernando Figueiredo
CEO, ABIQUIM
Latin America Petrochemicals and Chemicals 2018 APLA Special Edition
Abiquim explains to GBR how Brazil can reverse the ailing fortunes of its petrochemical industry.
Bert Gutierrez
GENERAL MANAGER – LATIN AMERICA, PILOT CHEMICAL COMPANY
Latin America Petrochemicals and Chemicals 2018 APLA Special Edition
Pilot Chemical Company explains its recent expansions as well as its view of the Mexican market.
Dean McPherson
HEAD, BUSINESS DEVELOPMENT, GLOBAL MINING, TMX GROUP
TMX Group speaks to GBR about the mining sector’s upswing and the capital raising models that junior companies are presently using.
Nigel Ferguson
MANAGING DIRECTOR, AVZ MINERALS LIMITED
MACIG 2019 Pre-Release
AVZ Minerals speaks to GBR about the options going forward for its huge Manono deposit in DRC.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
